Clinical Trial Update: Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gefitinib plus docetaxel as salvage therapy in advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Iressa (Gefitinib) (Gefitinib)
• Taxotere (docetaxel) (docetaxel)

Snippet

Sponsor: University of Pittsburgh | Conditions: Cancer | Phase 2 | Status: COMPLETED